Related Experiment Videos
Injection related anxiety in insulin-treated diabetes
A Zambanini1, R B Newson, M Maisey
1Section of Clinical Pharmacology, Imperial College School of Medicine, Chelsea & Westminster Hospital, London, UK. andyzamb@globalnet.co.uk
Diabetes Research and Clinical Practice
|January 7, 2000
Summary
Injection anxiety and phobia are common in insulin-treated diabetes patients, affecting compliance and quality of life. This anxiety is linked to general anxiety levels, impacting treatment adherence.
Area of Science:
- Endocrinology
- Psychology
- Diabetes Management
Background:
- Injection anxiety and phobia can negatively impact diabetes management.
- Understanding the prevalence and correlates of injection anxiety is crucial for improving patient outcomes.
Purpose of the Study:
- To assess the prevalence of injection-related anxiety and phobia in insulin-treated diabetes patients.
- To explore the association between injection anxiety, general anxiety, and treatment adherence.
Main Methods:
- A cross-sectional study involving 115 insulin-treated patients (Type 1 and Type 2) with diabetes.
- Patients completed a questionnaire assessing injection anxiety score (IAS) and general anxiety score (GAS).
Main Results:
- 14% of patients avoided injections due to anxiety; 42% worried about increased injection frequency.
- 28% had an IAS >= 3, with significant correlations between IAS and GAS.
- General anxiety scores were associated with injection avoidance and concerns about injection frequency.
Conclusions:
- Insulin injection anxiety and phobia are prevalent in diabetes patients requiring insulin.
- Injection anxiety is associated with higher general anxiety levels, potentially affecting treatment compliance.